Cautionary findings on acquired immunodeficiency from anti-CD20 MS therapyMay 1, 2020Multiple Sclerosis
Database will collect data on COVID-19 in patients with MSApril 16, 2020COVID-19 UpdatesMultiple Sclerosis
FDA approves ozanimod for relapsing and secondary progressive forms of MSMarch 26, 2020Multiple Sclerosis
Clinicians petition government for national quarantineMarch 18, 2020COVID-19 UpdatesBusiness of MedicineMixed TopicsMultiple Sclerosis
Teriflunomide increases the likelihood of achieving NEDA in relapsing-remitting MSMarch 12, 2020Multiple Sclerosis
Manual dexterity may decline more rapidly in pediatric-onset MSMarch 11, 2020Multiple SclerosisPediatrics
Age does not appear to affect efficacy of siponimod in secondary progressive MSMarch 10, 2020Multiple Sclerosis
